Home ยป “Daratumumab Monotherapy Safety and Efficacy in Indian Relapsed/Refractory Multiple Myeloma Patients”

“Daratumumab Monotherapy Safety and Efficacy in Indian Relapsed/Refractory Multiple Myeloma Patients”

by satcit

https://pubmed.ncbi.nlm.nih.gov/38116642

Daratumumab monotherapy shows acceptable safety and consistent efficacy in Indian patients with relapsed/refractory multiple myeloma.

You may also like

Leave a Comment